Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients
Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients
p62: Metabolism and the tumour microenvironment
Cancer cells plasticity and drug resistance
Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions
Editor's Choice for April 2016
Drugging “undruggable” transcription factor drivers in cancer
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer
Elucidation and pharmacological targeting of tumour checkpoint dependencies
New technology can potentially overcome CAR T-cell limitations
AML17 Trial results: maximum dosage of daunorubicin in AML
AML during pregancy